Disclaimer: Early release articles are not considered as final versions. Any changes will be reflected in the online version in the month the article is officially released.
Volume 31, Number 5—May 2025
Dispatch
Administration of L-type Bovine Spongiform Encephalopathy to Macaques to Evaluate Zoonotic Potential
Table
Detection of PrPres in tissue samples obtained from macaques orally challenged with L-BSE prions in study of oral transmission of L-type bovine spongiform encephalopathy in macaques to evaluate zoonotic potential*
Sample location |
PMCA, no. positive/no. total |
WB, orally challenged animals |
IHC, orally challenged animals |
|||||||||
Orally challenged animals |
Negative controls |
|||||||||||
18 |
19 |
9086 |
1004 |
9040 |
18 |
19 |
18 |
19 |
||||
Nerve tissues | ||||||||||||
Cerebral cortex, frontal lobe; PTA, PBS | 0/2, 0/2 | 0/2, 0/2 | ND | 0/2, 0/2 | 0/2, 0/2 | Neg | Neg | Neg | Neg | |||
Cerebral cortex, temporal lobe | ND | ND | ND | ND | ND | Neg | Neg | Neg | Neg | |||
Cerebral cortex, parietal lobe | ND | ND | ND | ND | ND | Neg | Neg | Neg | Neg | |||
Cerebral cortex, occipital lobe | ND | ND | ND | ND | ND | Neg | Neg | Neg | Neg | |||
Hippocampus | ND | ND | ND | ND | ND | Neg | Neg | Neg | Neg | |||
Thalamus | ND | ND | ND | ND | ND | Neg | Neg | Neg | Neg | |||
Cerebellum | ND | ND | ND | ND | ND | Neg | Neg | Neg | Neg | |||
Cervical cord; EtOH, PBS | 0/2, 0/2 | 0/2, 1/2 | 0/2, 0/2 | 0/2, 0/2 | 0/2, 0/2 | Neg | Neg | Neg | Neg | |||
Thoracic cord; EtOH, PBS | 0/2, 1/2 | 0/2, 1/2 | 0/2, 0/2 | 0/2, 0/2 | 0/2, 0/2 | Neg | Neg | Neg | Neg | |||
Lumbar cord; EtOH, PBS | 0/2, 0/2 | 0/2, 0/2 | 0/2, 0/2 | 0/2, 0/2 | 0/2, 0/2 | Neg | Neg | Neg | Neg | |||
Median nerve, PTA | 2/2 | 1/2 | ND | ND | ND | Neg | Neg | Neg | Neg | |||
Sciatic nerve, PTA |
0/2 |
0/2 |
ND |
ND |
ND |
Neg |
Neg |
Neg |
Neg |
|||
Secondary lymphoid tissues | ||||||||||||
Spleen, PTA | 1/2 | 0/2 | ND | ND | 0/2 | Neg | Neg | Neg | Neg | |||
Tonsil, PTA | 1/2 | 2/2 | 0/2 | 0/2 | 0/2 | ND | ND | ND | ND | |||
Submandibular lymph node, PTA | 0/2 | 0/2 | 0/2 | ND | 0/2 | Neg | Neg | Neg | Neg | |||
Inguinal lymph nodes, PTA | 1/2 | 2/2 | ND | ND | ND | ND | ND | ND | ND | |||
Mesenteric lymph node, PTA |
1/2 |
1/2 |
0/2 |
0/2 |
0/2 |
ND |
ND |
ND |
ND |
|||
Primary lymphoid tissues | ||||||||||||
Thymus, PTA |
0/2 |
2/2 |
ND |
ND |
ND |
ND |
ND |
ND |
ND |
|||
Others | ||||||||||||
Submaxillary gland, PTA | 2/2 | 1/2 | ND | ND | ND | ND | ND | ND | ND | |||
Ileum, PTA |
2/2 |
2/2 |
0/2 |
0/2 |
0/2 |
Neg |
Neg |
Neg |
Neg |
|||
*Bold indicates positive results. EtOH, ethanol precipitation; IHC, immunohistochemistry; ND, not determined; neg, negative; PBS, suspension in phosphate-buffered saline; PMCA, protein misfolding cyclic amplification; PrPres, PrPSc-like proteinase K–resistant prion proteins; PTA, sodium phosphotungstic acid precipitation; WB, western blot. |
1These authors were co–principal investigators.
Page created: March 21, 2025
Page updated: April 15, 2025
Page reviewed: April 15, 2025
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.